Showing results (51-60 of 180) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|August 19, 2025
Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working partyDrazen Pulanic, Christophe Peczynski, William Boreland, et al.
Bone Marrow Transplantation|January 7, 2023
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSebastian Giebel, Myriam Labopin, Mohamed Houhou, et al.
Blood Advances|July 16, 2025
Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemiaXavier Poire, Myriam Labopin, Emmanuelle Polge, et al.
Bone Marrow Transplantation|March 22, 2024
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie CellulaireSara Villar, Sylvie Chevret, Xavier Poire, et al.
Blood Advances|September 15, 2021
In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO studyRaynier Devillier, Edouard Forcade, Alice Garnier, et al.
Journal of Hematology & Oncology|October 22, 2018
Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCCFlorent Malard, Myriam Labopin, Christina Cho, et al.
American Journal of Hematology|August 31, 2024
Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationFrédéric Baron, Myriam Labopin, Jurjen Versluis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2023
Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working PartyAli Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, et al.
Oncotarget|June 22, 2018
Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxisClaire Calmettes, Frederic Gabriel, Elodie Blanchard, et al.
Bone Marrow Transplantation|April 1, 2025
Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular TherapyDavid Michonneau, Florent Malard, Sophie Le Grand, et al.
Pageof 18